Chargement en cours...
Beyond Telaprevir and Boceprevir: Resistance and New Agents for Hepatitis C Virus Infection
The addition of the hepatitis C virus (HCV) protease inhibitors telaprevir and boceprevir to peginterferon alfa with ribavirin therapy has increased cure rates in HCV infection. Numerous other direct-acting antivirals (DAAs) are in advanced stages of development, including next-generation protease i...
Enregistré dans:
| Publié dans: | Top Antivir Med |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
IAS-USA
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148907/ https://ncbi.nlm.nih.gov/pubmed/23154254 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|